R
REGN
REGNUnverified8 segments tracked|10 years of data|Annual (10-K)
Total Revenue
$6.1B6.0%
FY2024
Operating Segments
8Active segments
Blended Margin
0.0%Operating margin
Highest Margin
0.0%Collaboration Revenue
Segment Shift
Collaboration Revenue has grown from 0.0% to 100.0% of total revenue since FY2014, with 0.0% operating margins.
Segment Revenue Over Time
Revenue Mix
Segment Breakdown — FY2024
| Segment | Revenue | Op. Income | Margin | % of Total | YoY |
|---|---|---|---|---|---|
| Collaboration Revenue | $6.1B | $0 | 0.0% | 100.0% | +10.1% |
| Collaborationand Contract Manufacturing | $0 | $0 | 0.0% | 0.0% | +0.0% |
| Other | $0 | $0 | 0.0% | 0.0% | +0.0% |
| Other Collaboration Agreements | $0 | $0 | 0.0% | 0.0% | +0.0% |
| Reimbursement Of Research And Development Expenses | $0 | $0 | 0.0% | 0.0% | +0.0% |
| Sanofis Share Of Libtayo USGross Profits | $0 | $0 | 0.0% | 0.0% | +0.0% |
| Amounts Recognized In Connection With Up Front Payments | $0 | $0 | 0.0% | 0.0% | +0.0% |
Want more? Unlock the full analysis.
Sign up free to access quarterly data, financial statements, trend analysis, geographic segments, Excel exports, and cross-company comparisons.
Get Started Free